Tool: DupCheckTool: DupCheck is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.

Project FlyerProject Flyer

Click here to download 
the NEWMEDS project flyer! 

consortium teaser

Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms

  Members Area

IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

logo University of Cambridge

Behavioural and Clinical Neuroscience Inst. and Dept. of Expt.Psychology, University of Cambridge
Downing St
CB2 3EB,

Participant's Leads

Prof. Trevor Robbins Prof. Trevor Robbins
Behavioural and Clinical Neuroscience Inst. and Dept. of Expt.Psychology, Head of Department 
E-Mail to Prof. Trevor Robbins Contact  

Group Lead

Dr. Sabine Bahn Dr. Sabine Bahn
Cambridge Centre for Neuropsychiatric Research, Institute of Biotechnology; Practising Clinical Psychiatris 
E-Mail to Dr. Sabine Bahn Contact  

Institute Presentation

UCAM will be the academic leader of WP02, will contribute substantially to WP3 and WP8. The laboratory of Professor Robbins will contribute to WP2 by devising and validation behavioural test batteries for rats and mice for assaying effects of drugs on cognition. Together with Drs TJ Bussey and L Saksida, this UCAM team will utilise touch-screen technology where appropriate and validate tests where necessary in neural terms before testing candidate cognitive enhancers. This team will recommend a test battery suitable for testing rats and mice, and also participate in the subsequent modelling of cognitive deficits in schizophrenia in collaboration with industrial partners.

The Robbins/Bussey/Saksida labs are part of the Dept. of Expt. Psychology and the Behavioural and Clinical Neuroscience Institute (funded by the MRC and Wellcome Trust). It has purpose built animal house facilities capable of housing 1000 rodents and with 20 test rooms containing about 120 operant or touch screen test chambers. The Robbins and Bussey/Saksida labs are currently funded by grants approximating 2 million euros from charitable organizations, including the Wellcome Trust, and industry.

The Bahn lab is part of The Institute of Biotechnology department within the Institute of Biotechnology of the University of Cambridge and is the only part of the University dedicated solely to biotechnology. The Bahn lab has been funded through the Stanley Foundation (>10 years) and has pioneered the application of profiling techniques in psychiatric diseases. There are more than 25 scientists currently in the laboratory applying molecular profiling techniques to furthering our understanding of psychiatric disorders.

04 The University of Cambridge